Read more...

In a study published Online First by JAMA's Archives of Internal Medicine, Raphael P. H. Meier, M.D., and his team from Geneva's University Hospitals and Faculty of Medicine in Switzerland declare: "Current evidence suggests that there is an association between bisphosphonate therapy and atypical femoral fractures, but the extent of this risk remains unclear...